ArticleJournal of oncology2021

Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study.

Samuel Luke Koramati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.